Alps Advisors Inc. Has $1.12 Million Holdings in Waters Co. (WAT)

Alps Advisors Inc. grew its stake in Waters Co. (NYSE:WAT) by 7.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,949 shares of the medical instruments supplier’s stock after buying an additional 394 shares during the period. Alps Advisors Inc.’s holdings in Waters were worth $1,122,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Bank of New York Mellon Corp boosted its stake in Waters by 4.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 4,542,036 shares of the medical instruments supplier’s stock worth $884,244,000 after purchasing an additional 183,060 shares during the period. Baillie Gifford & Co. boosted its stake in Waters by 0.3% during the 3rd quarter. Baillie Gifford & Co. now owns 2,564,749 shares of the medical instruments supplier’s stock worth $499,305,000 after purchasing an additional 8,810 shares during the period. Janus Henderson Group PLC boosted its stake in Waters by 1.5% during the 3rd quarter. Janus Henderson Group PLC now owns 2,087,397 shares of the medical instruments supplier’s stock worth $406,376,000 after purchasing an additional 29,978 shares during the period. Franklin Resources Inc. boosted its stake in Waters by 1.6% during the 3rd quarter. Franklin Resources Inc. now owns 983,235 shares of the medical instruments supplier’s stock worth $191,416,000 after purchasing an additional 15,564 shares during the period. Finally, Morgan Stanley boosted its stake in Waters by 188.1% during the 3rd quarter. Morgan Stanley now owns 527,562 shares of the medical instruments supplier’s stock worth $102,707,000 after purchasing an additional 344,432 shares during the period. Institutional investors and hedge funds own 96.14% of the company’s stock.

Shares of Waters stock opened at $232.35 on Tuesday. The firm has a market cap of $17.50 billion, a price-to-earnings ratio of 28.03, a PEG ratio of 2.28 and a beta of 1.17. The company has a quick ratio of 2.01, a current ratio of 2.26 and a debt-to-equity ratio of 0.61. Waters Co. has a one year low of $167.93 and a one year high of $233.48.

Waters (NYSE:WAT) last announced its quarterly earnings data on Wednesday, January 23rd. The medical instruments supplier reported $2.87 EPS for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.23. The company had revenue of $715.00 million during the quarter, compared to the consensus estimate of $702.74 million. Waters had a net margin of 24.54% and a return on equity of 34.18%. Waters’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.51 EPS. On average, equities research analysts forecast that Waters Co. will post 9.35 earnings per share for the current year.

WAT has been the subject of a number of analyst reports. Bank of America upgraded shares of Waters from an “underperform” rating to a “neutral” rating in a research report on Thursday, January 3rd. JPMorgan Chase & Co. cut their price objective on shares of Waters from $200.00 to $185.00 and set a “neutral” rating for the company in a research report on Wednesday, October 24th. Barclays cut their price objective on shares of Waters from $200.00 to $190.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 24th. UBS Group cut their price objective on shares of Waters from $210.00 to $200.00 and set a “neutral” rating for the company in a research report on Wednesday, October 24th. Finally, Needham & Company LLC initiated coverage on shares of Waters in a research report on Wednesday, January 2nd. They set a “hold” rating and a $177.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $208.99.

In other news, Director Christopher A. Kuebler sold 8,000 shares of the stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $199.67, for a total value of $1,597,360.00. Following the completion of the transaction, the director now owns 18,911 shares in the company, valued at approximately $3,775,959.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Thomas P. Salice sold 2,000 shares of the stock in a transaction dated Wednesday, January 30th. The shares were sold at an average price of $231.59, for a total transaction of $463,180.00. Following the completion of the transaction, the director now owns 20,010 shares of the company’s stock, valued at approximately $4,634,115.90. The disclosure for this sale can be found here. Insiders sold a total of 97,249 shares of company stock valued at $20,981,857 in the last quarter. Insiders own 0.98% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.com-unik.info/2019/02/12/alps-advisors-inc-has-1-12-million-holdings-in-waters-co-wat.html.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: Why is the price-sales ratio important?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit